Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Results: Patheon 4Q12 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Results: Patheon 4Q12

CMO revenues up 18% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon

4Q Revenues: $210.0 million (flat) 

4Q Loss: $23.1 million (loss of $9.9 million in 4Q11)

YTD Revenues: $749.1 million (+7%)

YTD Loss: $106.7 million (loss of $16.4 million YTD11)

Comments: Commercial manufacturing revenues in the quarter were $172.7 million, up 18%, and for the year were $610.7 million, up 7%. Pharmaceutical Development Services revenues in the quarter were $37.5 million, up 7%, and for the year were $138.4 million, up 9%. The loss before discontinued operations was $106.4 million YTD compared to a loss of $15.8 million last year, primarily due to the asset impairment charge of $57.9 million related to closing the Swindon, UK facility.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters